Bimekizumab Efficacy in Patients with Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 years of Treatment in 5 Phase 3/3b Trials. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s308. https://doi.org/10.25251/skin.8.supp.308